Discover 612 paid clinical trials in Omaha, Nebraska. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Omaha hosts numerous active clinical trials targeting diseases such as cancer, asthma, and autoimmune disorders like lupus. The cityās leading research institutions are recruiting participants, both as a healthy volunteer and those looking for studies related to specific health conditions, offering opportunities to take part in groundbreaking research and access innovative treatments.
Filter
2
Filter results
Results: 612
FeaturedActive & Responsive
Type 2 Diabetes Studies on Blood Sugar and Weight Management for Adults Not on Insulin
for
Diabetes Mellitus, Type 2, Obesity
Location: Omaha NE, Lincoln NE, Norfolk NE, Saint Louis MO,
Location: Omaha NE, Lincoln NE, Norfolk NE, Munster IN, Hobart IN,
Sex: All
Age: 18+
Recruiting
FeaturedActive & Responsive
C. diff Vaccine Studies for Adults 65+ at Higher Risk of Infection
for
Clostridium Infections
Location: Omaha NE, Sioux City IA, Grand Island NE,
Sex: All
Age: 65+
Recruiting
Participants receive up to $1,470 for time and travel
FeaturedActive & Responsive
Asthma Control Studies for Adults With Ongoing Symptoms Despite a Daily Inhaler
for
Asthma
Location: Omaha NE, Grand Island NE, Austin TX, Charleston SC,
Sex: All
Age: 18 - 70+
Recruiting
FeaturedActive & Responsive
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
for
Metastatic Breast Cancer
Location: Omaha NE, Saint Paul MN, Zion IL, Germantown TN,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT03424005
Phase 1, Phase 2, Recruiting
Featured
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
for
Ovarian Cancer
Location: Omaha NE, Chicago IL, Denver CO, San Antonio TX,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT07278336
Phase 1, Recruiting
Featured
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
for
Atherosclerosis
Location: Omaha NE, Minneapolis MN, St Louis MO, Hammond IN,
Sponsor: Genentech, Inc.
Sex: All
Age: 18+
Code: NCT07448038
Phase 2, Recruiting
Featured
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
for
Severe Alopecia Areata
Location: Omaha NE, Indianapolis IN, Fairborn OH, San Antonio TX,
Sponsor: AbbVie
Sex: All
Age: 6 - 17
Code: NCT07772492
Phase 3, Recruiting
Featured
A Study to Assess Adverse Events and Effectiveness of Gel Stent (XEN63) Implantation Using Ab Interno and Ab Externo Approaches in Adult Participants With Glaucoma
for
Primary Open Angle Glaucoma
Location: Omaha NE, Minneapolis MN, Oklahoma City OK, Kenosha WI,
Sponsor: AbbVie
Sex: All
Age: 45+
Code: NCT06822738
Phase 3, Recruiting
Featured
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
for
Chronic Migraine
Location: Papillion NE, Little Rock AR, Evansville IN,
Sponsor: AbbVie
Sex: All
Age: 12 - 17
Code: NCT06810505
Phase 3, Recruiting
Featured
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
for
Migraine
Location: Papillion NE, Ames IA, Overland Park KS, Wichita KS,
Sponsor: AbbVie
Sex: All
Age: 6 - 17
Code: NCT05125302
Phase 3, Recruiting
Featured
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
for
Alopecia Areata
Location: Omaha NE, Indianapolis IN, Caledonia MI, Dallas TX,
Sponsor: AbbVie
Sex: All
Age: 12 - 63
Code: NCT06012240
Phase 3, Recruiting
Featured
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Omaha NE, Lincoln NE, Rochester MN, Springdale AR,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT05650632
Phase 1, Recruiting
Featured
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
for
Metastatic Colorectal Cancer
Location: Omaha NE, Kansas City MO, Hinsdale IL, Chicago IL,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06820463
Phase 2, Recruiting
Featured
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
for
Non-Small Cell Lung Cancer, c-MET
Location: Omaha NE, Lincoln NE, Springfield IL, Niles IL,